The Crypto Basic
Moderna (NASDAQ: MRNA) shares reversed an early 9.6% premarket gain on Friday, despite the vaccine maker reporting better-than-expected third-quarter earnings and raising its 2026 revenue growth forecast to 15%–25%, from…
Related articles
-
Gold Price Forecast Faces December Fed Test as $3,900 Support Comes Into View
Brave New Coin Published 04.11.2026 19:41
-
XRP and ADA Edge Closer to Deeper Losses as Sellers Test Key Floors
Crypto Daily Published 07.11.2026 06:39
-
Ethereum devs won’t fork Glamsterdam on Hoodi until smart contract risks resolved
Cointelegraph Published 06.11.2026 13:23
-
Pi Network’s PI Rockets 8% From ATL as Bitcoin Struggles to Hold $74K: Market Watch
CryptoPotato Published 10.11.2026 09:46
-
Why Major US Companies Are Pushing Back Against Stock Tokenization: MEXC CEO
Bitcoin.com Published 05.11.2026 09:30
-
US Midterms Hit One Class of Stocks the Hardest as Trump Mulls Hegseth Removal
BeInCrypto Published 04.11.2026 22:00
-
FCA Standardizes "Sterling Anchor" Rules as UK Finalizes Crypto Perimeter
Crypto Daily Published 04.11.2026 12:13
-
Blockchain.com Adds Trading API for Institutional Crypto Execution
NewsBTC Published 10.11.2026 06:00